Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis

Mikołaj Ogrodnik(Mayo Clinic), Yi Zhu(Mayo Clinic), Larissa Prata(Mayo Clinic), Tamar Tchkonia(Mayo Clinic), Patrick Krüger(Newcastle Hospitals - Campus for Ageing and Vitality), Edward Fielder(Newcastle Hospitals - Campus for Ageing and Vitality), Stella Victorelli(Newcastle Hospitals - Campus for Ageing and Vitality), Rifqha A. Ruswhandi(Newcastle Hospitals - Campus for Ageing and Vitality), Nino Giorgadze(Mayo Clinic), Tamar Pirtskhalava(Mayo Clinic), Oleg Podgorni(Stony Brook School), Grigori Enikolopov(Moscow Institute of Physics and Technology), Kurt O. Johnson(Mayo Clinic), Ming Xu(Mayo Clinic), Christine Inman(Mayo Clinic), Allyson K. Palmer(Mayo Clinic), Marissa Schafer(Mayo Clinic), Moritz Weigl(Mayo Clinic), Yuji Ikeno(The University of Texas at San Antonio Health Science Center), Terry C. Burns(Mayo Clinic), João F. Passos(Mayo Clinic in Florida), Thomas von Zglinicki(Newcastle Hospitals - Campus for Ageing and Vitality), James L. Kirkland(Mayo Clinic), Diana Jurk(Mayo Clinic)
Cell Metabolism
January 3, 2019
Cited by 537Open Access
Full Text

Abstract

-expressing senescent cells can be eliminated, and senolytic drugs dasatinib and quercetin. We found that obesity results in the accumulation of senescent glial cells in proximity to the lateral ventricle, a region in which adult neurogenesis occurs. Furthermore, senescent glial cells exhibit excessive fat deposits, a phenotype we termed "accumulation of lipids in senescence." Clearing senescent cells from high fat-fed or leptin receptor-deficient obese mice restored neurogenesis and alleviated anxiety-related behavior. Our study provides proof-of-concept evidence that senescent cells are major contributors to obesity-induced anxiety and that senolytics are a potential new therapeutic avenue for treating neuropsychiatric disorders.


Related Papers

No related papers found

Powered by citation graph analysis